跳至主要内容
临床试验/NCT05573048
NCT05573048Enrolling By Invitation不适用

Optical Fusion Trans-Perineal Grid

Mayo Clinic1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2022年10月4日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
Enrolling By Invitation
发起方
Mayo Clinic
入组人数
20
试验地点
1
主要终点
Needle placement accuracy

研究概览

简要总结

The purpose of this research is to evaluate a new needle guide grid utilizing Clear Guide SCENERGY - MR with a grid embedded with VisiMARKER II to autoregister and target the prostate aiding in needle placement positioning. The proceduralist can utilize this technology to find the best needle path to target within the pelvis.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Device Feasibility
盲法
None

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Scheduled for a MR guided biopsy or ablation.
  • One, two, or three tumor suspicious regions identified on multiparametric MRI.
  • Tolerance for anesthesia/sedation.
  • Ability to give informed consent.

排除标准

  • Presence of any condition (e.g., metal implant, shrapnel) not compatible with MRI.
  • History of other primary non-skin malignancy within previous three years.

研究组 & 干预措施

Trans-Perineal Grid for prostate interventions

Experimental

Subjects will have the trans-perineal guide grid placed the prostate biopsy or ablation procedure.

干预措施: Trans-Perineal Grid (Device)

结局指标

主要结局

Needle placement accuracy

时间窗: Baseline

Number of needle placements to successfully match target and needle tip position assessed by direct MR imaging and

次要结局

未报告次要终点

研究者

发起方
Mayo Clinic
申办方类型
Other
责任方
Principal Investigator
主要研究者

David A. Woodrum

Principal Investigator

Mayo Clinic

研究点 (1)

Loading locations...

相似试验